{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:07:32Z","timestamp":1788973652217,"version":"build-2803163510"},"reference-count":33,"publisher":"American Chemical Society (ACS)","issue":"35","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["356056"],"award-info":[{"award-number":["356056"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Sy?p?s??ti?","doi-asserted-by":"publisher","award":["230130"],"award-info":[{"award-number":["230130"]}],"id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer immunotherapies show clinical promise but often rely on T-cell priming and are limited by tumor heterogeneity and the immunosuppressive tumor microenvironment (TME). Innate immune activation offers a complementary approach, with specific aim in natural killer (NK) cell activation for antigen-independent response. Biomimetic nanoparticles combining virus-like morphology with cell membrane (CM) coating offer a strategy to engage this innate immune axis. This study investigates virus-like mesoporous silica nanoparticles (VLPSi) with tunable spikes, surface functionalization, and CM coating as innate immunity modulators. Optimization revealed that longer spikes, amine functionalization, and CM coating synergistically enhance NK cell activation within human PBMCs, as indicated by CD69\/CD25 upregulation and IFN-\u03b3 secretion. CD14+ monocyte depletion attenuated activation, identifying monocyte-dependent crosstalk as a key mechanism. In purified NK cells, engineered CM-coated VLPSi induced early activation and supported feeder-free expansion. These results define topology, surface chemistry, and CM coating as parameters for innate immune modulation.<\/jats:p>","DOI":"10.1021\/acs.nanolett.6c01832","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:24:23Z","timestamp":1788301463000},"page":"11679-11686","source":"Crossref","is-referenced-by-count":0,"title":["Biomimetic\nVirus-Like Mesoporous Silica Nanoparticles\nActivate NK Cells Indirectly via Monocyte Crosstalk"],"prefix":"10.1021","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2470-2961","authenticated-orcid":true,"given":"Minna","family":"Sivonen","sequence":"first","affiliation":[{"name":"University of Eastern Finland , , Yliopistonranta 8 , ,","place":["Kuopio, Finland, 70211"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silja","family":"Saarela","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonranta 8 , ,","place":["Kuopio, Finland, 70211"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Wang","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonranta 8 , ,","place":["Kuopio, Finland, 70211"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Saari","sequence":"additional","affiliation":[{"name":"Finnish Red Cross Blood Service , , Haartmaninkatu 8 , ,","place":["Helsinki, Finland, 00290"]},{"name":"University of Eastern Finland , , Neulaniementie 2 , ,","place":["Kuopio, Finland, 70210"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmi","family":"Ja\u0308rvela\u0308","sequence":"additional","affiliation":[{"name":"Finnish Red Cross Blood Service , , Haartmaninkatu 8 , ,","place":["Helsinki, Finland, 00290"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Andersson","sequence":"additional","affiliation":[{"name":"Finnish Red Cross Blood Service , , Haartmaninkatu 8 , ,","place":["Helsinki, Finland, 00290"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enkhzaya","family":"Batnasan","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonranta 8 , ,","place":["Kuopio, Finland, 70211"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Latonen","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonranta 8 , ,","place":["Kuopio, Finland, 70211"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helka","family":"Go\u0308o\u0308s","sequence":"additional","affiliation":[{"name":"Finnish Red Cross Blood Service , , Haartmaninkatu 8 , ,","place":["Helsinki, Finland, 00290"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8153-1070","authenticated-orcid":true,"given":"Vesa-Pekka","family":"Lehto","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonranta 8 , ,","place":["Kuopio, Finland, 70211"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3177-4709","authenticated-orcid":true,"given":"Wujun","family":"Xu","sequence":"additional","affiliation":[{"name":"University of Eastern Finland , , Yliopistonranta 8 , ,","place":["Kuopio, Finland, 70211"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"2026090911330901800_cit1","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/curroncol29050247","article-title":"Immune Checkpoint Inhibitors\nin Cancer Therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Current Oncology"},{"key":"2026090911330901800_cit2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41392-025-02269-w","article-title":"CAR-T cell therapy for\ncancer: current challenges and future directions","volume":"10","author":"Zugasti","year":"2025","journal-title":"Signal Transduct Target Ther."},{"key":"2026090911330901800_cit3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41586-024-08507-5","article-title":"A neoantigen vaccine generates antitumour immunity\nin renal cell carcinoma","volume":"639","author":"Braun","year":"2025","journal-title":"Nature"},{"key":"2026090911330901800_cit4","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41586-024-08508-4","article-title":"RNA neoantigen vaccines\nprime long-lived CD8+ T cells in pancreatic cancer","volume":"639","author":"Sethna","year":"2025","journal-title":"Nature"},{"key":"2026090911330901800_cit5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41423-025-01316-4","article-title":"Eliciting\nantitumor\nimmunity via therapeutic cancer vaccines","volume":"22","author":"Peng","year":"2025","journal-title":"Cell\nMol. Immunol"},{"key":"2026090911330901800_cit6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41590-022-01127-z","article-title":"Innate lymphoid\ncells and cancer","volume":"23","author":"Jacquelot","year":"2022","journal-title":"Nat. Immunol"},{"key":"2026090911330901800_cit7","doi-asserted-by":"publisher","first-page":"1420205","DOI":"10.3389\/fimmu.2024.1420205","article-title":"The basic biology of\nNK cells and its application in tumor immunotherapy","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Immunol."},{"key":"2026090911330901800_cit8","doi-asserted-by":"publisher","first-page":"102333","DOI":"10.1016\/j.nano.2020.102333","article-title":"Cell membrane-encapsulated magnetic nanoparticles for\nenhancing natural killer cell-mediated cancer immunotherapy","volume":"32","author":"Wu","year":"2021","journal-title":"Nanomedicine"},{"key":"2026090911330901800_cit9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3390\/pharmaceutics16040531","article-title":"Cell Membrane-Coated Biomimetic Nanoparticles in Cancer\nTreatment","volume":"16","author":"Zhang","year":"2024","journal-title":"Pharmaceutics"},{"key":"2026090911330901800_cit10","doi-asserted-by":"publisher","first-page":"16728","DOI":"10.1038\/srep16728","article-title":"Virus-like nanostructures\nfor tuning immune\nresponse","volume":"5","author":"Mammadov","year":"2015","journal-title":"Sci. Rep."},{"key":"2026090911330901800_cit11","doi-asserted-by":"publisher","first-page":"5726","DOI":"10.1038\/s41467-021-26052-x","article-title":"Cell membrane coating\nintegrity affects the internalization mechanism of biomimetic nanoparticles","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"2026090911330901800_cit12","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1021\/nl500618u","article-title":"Cancer cell membrane-coated\nnanoparticles for anticancer\nvaccination and drug delivery","volume":"14","author":"Fang","year":"2014","journal-title":"Nano Lett."},{"key":"2026090911330901800_cit13","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.292","article-title":"Membrane engineering\nof cell membrane biomimetic nanoparticles for nanoscale therapeutics","volume":"11","author":"Zhang","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"2026090911330901800_cit14","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41578-021-00385-x","article-title":"Clinical translation of silica nanoparticles","volume":"6","author":"Janjua","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"2026090911330901800_cit15","doi-asserted-by":"publisher","first-page":"1504124","DOI":"10.3389\/fimmu.2024.1504124","article-title":"Virus-like\nparticle: a nano-platform that delivers cancer antigens to elicit\nan anti-tumor immune response","volume":"15","author":"Ning","year":"2025","journal-title":"Front. Immunol."},{"key":"2026090911330901800_cit16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jconrel.2021.01.012","article-title":"The impact\nof size on\nparticle drainage dynamics and antibody response","volume":"331","author":"Zinkhan","year":"2021","journal-title":"J. Controlled Release"},{"key":"2026090911330901800_cit17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1021\/acscentsci.7b00257","article-title":"Facile Synthesis of\nUniform Virus-like Mesoporous Silica Nanoparticles for Enhanced Cellular\nInternalization","volume":"3","author":"Wang","year":"2017","journal-title":"ACS Cent Sci."},{"key":"2026090911330901800_cit18","doi-asserted-by":"publisher","first-page":"45917","DOI":"10.1021\/acsami.4c07106","article-title":"High\nCellular Internalization of Virus-Like Mesoporous\nSilica Nanoparticles Enhances Adaptive Antigen-Specific Immune Responses\nagainst Cancer","volume":"16","author":"Phan","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2026090911330901800_cit19","doi-asserted-by":"publisher","first-page":"115338","DOI":"10.1016\/j.colsurfb.2025.115338","article-title":"Mechanism\nof biomimetic virus-like nanoparticles\nin triggering immune response elucidated by proteomics","volume":"259","author":"Wang","year":"2026","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"2026090911330901800_cit20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.micromeso.2019.04.050","article-title":"Systemic investigation\nof in vitro\nand in vivo safety, toxicity and degradation of mesoporous silica\nnanoparticles synthesized using commercial sodium silicate","volume":"284","author":"Bhavsar","year":"2019","journal-title":"Microporous Mesoporous Mater."},{"key":"2026090911330901800_cit21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12943-023-01737-7","article-title":"NK cells are never\nalone: crosstalk and communication in tumour microenvironments","volume":"22","author":"Zhou","year":"2023","journal-title":"Mol. Cancer"},{"key":"2026090911330901800_cit22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s44222-023-00030-y","article-title":"Engineering\ncytokine therapeutics","volume":"1","author":"Deckers","year":"2023","journal-title":"Nature Reviews Bioengineering"},{"key":"2026090911330901800_cit23","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/pharmaceutics14122728","article-title":"PLGA-Based\nNanomedicine: History of Advancement\nand Development in Clinical Applications of Multiple Diseases","volume":"14","author":"Alsaab","year":"2022","journal-title":"Pharmaceutics"},{"key":"2026090911330901800_cit24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41419-025-08021-0","article-title":"Combined IFN-\u03b3 and TNF-\u03b1 treatment enhances\nthe susceptibility of breast cancer cells and spheroids to Natural\nKiller cell-mediated killing","volume":"16","author":"Barberini","year":"2025","journal-title":"Cell Death Dis."},{"key":"2026090911330901800_cit25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/j.gastro.2014.03.046","article-title":"Monocytes\nactivate natural killer cells via inflammasome-induced\ninterleukin 18 in response to hepatitis C virus replication","volume":"147","author":"Serti","year":"2014","journal-title":"Gastroenterology"},{"key":"2026090911330901800_cit26","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/ni1402","article-title":"Mutual activation of\nnatural killer cells and monocytes mediated by NKp80-AICL interaction","volume":"7","author":"Welte","year":"2006","journal-title":"Nat. Immunol"},{"key":"2026090911330901800_cit27","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/icb.2013.96","article-title":"Cell biological steps and checkpoints in accessing\nNK cell cytotoxicity","volume":"92","author":"MacE","year":"2014","journal-title":"Immunol Cell Biol."},{"key":"2026090911330901800_cit28","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.jcyt.2023.07.002","article-title":"2B4 inhibits\nthe apoptosis of natural killer cells through phosphorylated\nextracellular signal-related kinase\/B-cell lymphoma 2 signal pathway","volume":"25","author":"Mou","year":"2023","journal-title":"Cytotherapy"},{"key":"2026090911330901800_cit29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jcyt.2016.02.006","article-title":"Natural killer cells\nstimulated with PM21 particles\nexpand and biodistribute in vivo: Clinical implications for cancer\ntreatment","volume":"18","author":"Oyer","year":"2016","journal-title":"Cytotherapy"},{"key":"2026090911330901800_cit30","doi-asserted-by":"publisher","first-page":"626098","DOI":"10.3389\/fimmu.2021.626098","article-title":"GMP-Compliant\nUniversal Antigen Presenting Cells (uAPC)\nPromote the Metabolic Fitness and Antitumor Activity of Armored Cord\nBlood CAR-NK Cells","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"2026090911330901800_cit31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","article-title":"NK cell-based cancer\nimmunotherapy: from basic biology to clinical\ndevelopment","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"2026090911330901800_cit32","doi-asserted-by":"publisher","first-page":"1227064","DOI":"10.3389\/fimmu.2023.1227064","article-title":"Cytokines\nimpact natural\nkiller cell phenotype and functionality against glioblastoma in vitro","volume":"14","author":"Sivonen","year":"2023","journal-title":"Front. Immunol."},{"key":"2026090911330901800_cit33","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3390\/cells13050451","article-title":"Building\na Better Defense:\nExpanding and Improving Natural Killer Cells for Adoptive Cell Therapy","volume":"13","author":"Maia","year":"2024","journal-title":"Cells"}],"container-title":["Nano Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.nanolett.6c01832","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/nalefd\/article-pdf\/26\/35\/11679\/67540798\/acs.nanolett.6c01832.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/nalefd\/article-pdf\/26\/35\/11679\/67540798\/acs.nanolett.6c01832.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:08:36Z","timestamp":1788970116000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/nalefd\/article\/26\/35\/11679\/5342496\/Biomimetic-Virus-Like-Mesoporous-Silica"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":33,"journal-issue":{"issue":"35","published-online":{"date-parts":[[2026,8,27]]},"published-print":{"date-parts":[[2026,9,9]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.nanolett.6c01832","relation":{},"ISSN":["1530-6984","1530-6992"],"issn-type":[{"value":"1530-6984","type":"print"},{"value":"1530-6992","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}